Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NET | MSFT |
|---|---|---|
| Price | $363.11 | $496.07 |
| Change today | ▲ 3.06% | ▼ 0.90% |
| Market cap | $129.30B | $3.68T |
| Return, 3 months | +62.5% | +36.0% |
| Return, year to date | +84.2% | +3.2% |
| Return, 1 year | +66.9% | -2.0% |
| P/E (TTM) | -626.1 | 27.6 |
| P/B | 79.8 | 8.3 |
| P/E percentile vs own 5y | 26th | 23rd |
| Dividend yield | – | 0.72% |
| Revenue growth (YoY, latest qtr) | +35.9% | +17.7% |
| Net profit growth (YoY) | -237.0% | +31.3% |
| Gross margin | 72.6% | 67.9% |
| Operating margin | -8.1% | 46.8% |
| Net margin | -8.2% | 40.3% |
| Return on equity | -14.4% | 34.0% |
| Analyst target vs. price | -1.0% | +15.6% |
| Analyst buy share | 84% | 97% |
| RSI (14) | 66 | 55 |
| 30-day volatility | 69.7% | 22.0% |
| Max drawdown, 1 year | -36.8% | -34.5% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.